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a b s t r a c t
Speciﬁc inbred strains and transgenic inhibin-a Simian Virus 40 T antigen (inha/Tag) mice are genetically
susceptible to gonadectomy-induced adrenocortical neoplasias. We identiﬁed altered gene expression in
prepubertally gonadectomized (GDX) inha/Tag and wild-type (WT) mice. Besides earlier reported Gata4
and Lhcgr, we found up-regulated Esr1, Prlr-rs1, and down-regulated Grb10, Mmp24, Sgcd, Rerg, Gnas,
Nfatc2, Gnrhr, Igf2 in inha/Tag adrenal tumors. Sex-steroidogenic enzyme genes expression (Srd5a1,
Cyp19a1) was up-regulated in tumors, but adrenal-speciﬁc steroidogenic enzyme (Cyp21a1, Cyp11b1,
Cyp11b2) down-regulated. We localized novel Lhcgr transcripts in adrenal cortex parenchyma and in
non-steroidogenic A cells, in GDX WT and in intact WT mice. We identiﬁed up-regulated Esr1 as a po-
tential novel biomarker of gonadectomy-induced adrenocortical tumors in inha/Tag mice presenting
with an inverted adrenal-to-gonadal steroidogenic gene expression proﬁle. A putative normal adrenal
remodeling or tumor suppressor role of the down-regulated genes (e.g. Grb10, Rerg, Gnas, and Nfatc2) in
the tumors remains to be addressed.
© 2017 Elsevier B.V. All rights reserved.
1. Introduction
The adrenal cortex is the steroidogenically active part of the
adrenal gland consisting of 3 layers, i.e., zona glomerulosa, zona
fasciculata and zona reticularis in humans, or x-zone in mice
(corresponding to human zona reticularis), which is a vestige of the
fetal adrenal cortex (Pihlajoki et al., 2015). Each layer expresses
speciﬁc steroidogenic enzymes that results in the zone-speciﬁc
production of mineralocorticoids, glucocorticoids or androgens,
respectively (Pihlajoki et al., 2015). In contrast to human zona
reticularis, the x-zone in postnatal mice does not produce andro-
gens due to inactivation by methylation of Cyp17a1, the enzyme
directing steroidogenesis to production of sex steroids (Pihlajoki
et al., 2015). The highly differentiated cells of the adrenal zones
do not proliferate, but are replaced by new cells migrating towards
medulla from the subcapsular niche of stem/progenitor cells
(Pihlajoki et al., 2015). This pool of progenitors has a common origin
with gonadal somatic cells, which forms the adreno-gonadal pri-
mordium in early embryonic life (Laufer et al., 2012; Pihlajoki et al.,
2015). Interestingly, following gonadectomy, some strains of inbred
mice (DBA/2J, NU/J) develop adrenocortical neoplasms that struc-
turally and functionally resemble ovarian theca and granulosa cells
(Bielinska et al., 2005; Bielinska et al., 2003).
Prepubertally gonadectomized inbred DBA/2J or NU/J mice
develop adrenal adenomas with two types of neoplastic cells, non-
steroidogenic A cells (gonadectomy-independent) originating from
the subcapsular region (Hofmann et al., 1960) and larger lipid-laden
B cells (gonadectomy-dependent) located between the foci of A
cells (Rosner et al., 1966), but still with unclear clonal origin. Only
the B cells are steroidogenic and express gonad-speciﬁc genes such
as Lhcgr, Gata4, and the steroidogenic enzymes Cyp17a1 and
Cyp19a1, resulting in a signiﬁcant estrogen production (Bielinska
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et al., 2003; Chrusciel et al., 2013; Krachulec et al., 2012). However,
unlike the aforementioned mouse models, human adrenocortical
tumors (ACT) produce mostly adrenal steroids (Stojadinovic et al.,
2003) and sex steroid production occurs only in 5% of all ACT
(Moreno et al., 2006). Interestingly, a large group of ACTs respond to
luteinizing hormone (LH)/choriogonadotropin (CG) stimuli
(Carlson, 2007) with production of cortisol, aldosterone or andro-
gens. This situation is usually correlated with chronically elevated
LH (menopause) or hCG (pregnancy) levels (Alevizaki et al., 2006;
Carlson, 2007; Saner-Amigh et al., 2006).
A common cause for human adrenal malignancies are TP53
germline (80% of pediatric and 6% of adult ACT cases) and somatic
(25e70% of adult ACC) mutations (Lerario et al., 2014). Inactivation
of p53 promotes development of neoplastic cells by enabling pro-
gression through the S-phase of the cell cycle, despite DNA damage
(Levine et al., 1991). Modeling of p53 inhibition is possible by
transgenic expression of the Simian Virus 40 T-antigen (SV40Tag),
and to date it has been successfully used to induce malignancies in
various mouse organs (Hudson and Colvin, 2016). Identifying the
molecular mechanisms leading to tumor formation and progres-
sion in animal models expressing SV40Tag might therefore provide
novel insights into human tumors induced by p53 inactivation.
Inha/Tag mice express SV40Tag oncogene under the inhibin a
promoter in a C57Bl/6 genetic background and have been well
established as a model for gonadal and adrenocortical tumorigen-
esis (Kananen et al., 1996; Rahman et al., 2004; Rilianawati et al.,
1998). Intact inha/Tag mice have been extensively used to study
gonadal tumorigenesis (Kananen et al., 1996; Kiiveri et al., 1999;
Rahman et al., 2004; Vuorenoja et al., 2007). To induce adreno-
cortical tumorigenesis, the inha/Tag mice need to be prepubertally
gonadectomized (Kananen et al., 1996). Generally, females develop
adrenal tumors faster and to larger size than males, with high in-
dividual variations of tumor volume and histological appearance
(Rahman et al., 2004). The tumors express highly inhibin alpha
(INHA), transcription factor GATA4 and luteinizing hormone/cho-
rionic gonadotropin receptor (LHCGR) (Kananen et al., 1996; Kiiveri
et al., 1999; Rahman et al., 2004; Rilianawati et al., 1998). Adreno-
cortical tumorigenesis in inha/Tag model has been shown to be
strictly gonadotropin dependent. Crossbreeding with mice lacking
gonadotropin releasing hormone (GnRH) (hpg mice) or treatment
with the GnRH antagonist cetrorelix prevented tumor formation
(Rilianawati et al., 2000). Moreover, crossbreeding the inha/Tag
mice with transgenic mice expressing bovine Lhb fused with the
human chorionic gonadotropin b-subunit C-terminal peptide
(bLHb-CTP) (Risma et al., 1995), resulted in a 10-fold higher LH
levels, and enhanced simultaneous development of gonadal and
adrenocortical tumors (Mikola et al., 2003). Until now, molecular
mechanisms of the adrenocortical tumor formation and progres-
sion in conjunction with the elevated LH and subsequent LHCGR
up-regulation remain largely unknown.
In this study, we used the inha/Tag male mouse model to
analyze the molecular basis of the LH-dependent adrenal tumori-
genesis. In doing so, we identiﬁed and validated novel biomarker
genes, complementing the earlier established LHCGR and GATA4
markers. We also revisited the Lhcgr transcript localization in
normal and neoplastic adrenal cells.
2. Materials and methods
2.1. Experimental animals and tissue preparation
Male inha/Tag and negative control littermate (C57Bl/6N) mice
were used as the animal model. Mice were kept in a speciﬁc
pathogen-free surrounding with controlled light (12 h light, 12 h
darkness) and temperature (21 ± 1 C), fed with mouse chow SDS
RM-3 (Witham, Essex, UK) and tap water ad libitum. The Ethics
Committees for animal experimentation of the Turku University
and the State Provincial Ofﬁce of Southern Finland approved the
animal experiments.
Prepubertal gonadectomy in inha/Tag and WT mice was per-
formed at 21e24 days of age. Surgery was performed under iso-
ﬂurane (2e4%) anesthesia (Isoﬂo, Orion Pharma, Turku, Finland)
and Temgesic (buprenorphine, 0.1 mg/kg/8 h) (Schering-Plough,
Brussels, Belgium) was administered as mid- and post-operative
analgesia. Seven-month-old GDX WT and inha/Tag, and intact WT
mice were sacriﬁced by exsanguination under isoﬂurane anes-
thesia. Tissue weights were recorded, adrenals snap-frozen in
liquid nitrogen, and/or ﬁxedwith 4% paraformaldehyde (PFA). From
each mouse about 900 ml - 1 ml of blood was collected into a tube
consisting 100 ml of 0,5 M sterile EDTA solution. Plasma was frac-
tioned by centrifugation at 3000 RPM for 10 min in 4 C and stored
in 80 C for further analysis.
2.2. Hormone measurements
LH levels in plasma were measured by immunoﬂuorometric
assay (DELFIA; PerkinElmer) as described previously (Haavisto
et al., 1993). Progesterone and testosterone blood plasma concen-
trations were analyzed by Elecsys® Progesterone II and Testos-
terone II assays (Roche Diagnostics, Basel, Switzerland), using
Cobas e411 immunoanalyzer (Roche Diagnostics, Basel,
Switzerland). Detection limits for progesterone and testosterone
were 0.10 nmol/l and 0.09 nmol/l respectively.
2.3. Microarray
To identify novel biomarker genes for adrenocortical tumors, we
compared adrenals of 7mo GDX inha/Tag and WT males. Total RNA
was extracted from frozen tissues (n ¼ 8/group) using RNeasy Mini
Kit (Qiagen, Germantown, MD), re-suspended in 50 ml of nuclease-
free water (Promega, Madison, WI), quantiﬁed spectrophotomet-
rically (NanoDrop; Thermo Fisher Scientiﬁc, Waltham, MA) and
then qualiﬁed using Bioanalyzer nano kit (Agilent Technologies,
Santa Clara, CA). The RNA stock was divided into two batches in
order to use the same template for both microarray and gene
expression validation by qPCR. RNA was transcribed (n ¼ 4/group)
using the MessageAmp II aRNA Ampliﬁcation Kit (Thermo Fisher
Scientiﬁc) and applied to Agilent whole mouse genome oligo
microarrays 4  44K (#GPL7202, Agilent Technologies) accordingly
to manufacturer's protocol (Agilent Technologies). The readout was
loaded into the Iimma R/Bioconductor package, normalized be-
tween arrays using the quantile normalization. After performing a
row-wise t-test, fold changes were log2-transformed. Genes with
fold change higher than 1.5 fold and p-value lower than 0.05 were
considered as differently expressed. Heatmaps were generated
using the gplot package in R. The list of signiﬁcantly differentially
expressed genes were uploaded to GOrilla (Eden et al., 2009) and
separate, process-based enrichment lists for up- and down-
regulated genes were generated.
2.4. Real-time quantitative PCR (qPCR)
Prior to qPCR, 900 ng of total RNA was DNaseI treated (Thermo
Fisher Scientiﬁc) and transcribed (60 min in 37 C) using Dy-
NAmo™ cDNA Synthesis Kit (#F470, Thermo Fisher Scientiﬁc).
qPCR was carried out on a CFX96 Real Time PCR Detection System
(BioRad, Vienna, Austria), using the DyNAmo™ Flash SYBR® Green
qPCR Kit (#F415, Thermo Fisher Scientiﬁc) with 15 ng of cDNA
template in total reaction volume of 20 ml, in duplicates. Conditions
were as follows: 95 C for 7 min, [95 C for 15 s, 54e62 C for 15 s,
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72 C for 15s] x 40, 72 C for 3 min, 65e95 Cmelt curve. Sequences
of primers are listed in Suppl. Table S1. Ct for each gene of interest
was normalized by 2e3 reference genes: cyclophilin A (Ppia), b-
glucuronidase (Gusb), and hypoxanthine phosphoribosyltransfer-
ase (Hprt1), validated for each experiment using Bio- Rad CFX
Manager software (BioRad). Gene expression was calculated using
qBase MSExcel VBA applet (Hellemans et al., 2007).
2.5. Immunohistochemistry
PFA ﬁxed parafﬁn embedded adrenal glands from intact and
GDX WT, and inha/Tag (n ¼ 4/group) were sectioned ±5 mm and
stored in darkness at þ4 C. Antigens were retrieved in 10 mM
citrate buffer (pH6), washed in TBS with 0,1% Tween20 (#P1379,
Sigma-Aldrich, Saint Louis, US-MO). Primary and secondary anti-
bodies were listed in Suppl. Table S2. HRP signal was visualized
after 10 min incubation with Liquid DAB þ Substrate Chromogen
System (Dako, Glostrup, Denmark). Slides were scanned by Pan-
noramic 250 Slide Scanner (3DHISTECH Ltd., Budapest, Hungary).
2.6. Densitometric analysis
Images from good-quality representative areas (at least 10 from
each slide) of GDX inha/Tag and WT adrenals (n ¼ 4/group) were
acquired with Pannoramic Viewer (3DHISTECH Ltd.) at 60X
magniﬁcation and analyzed by Fiji (Schindelin et al., 2012). In brief,
Hematoxylin-Diaminobenzidine (H-DAB) color deconvolution was
performed and units of intensity occupied by DAB staining (grey)
were counted. Intensity numbers were transformed into optical
density (OD) values using formula OD ¼ log (255/Mean intensity).
2.7. In situ hybridization
We used RNAscope® 2.5 HD Reagent Kit-BROWN (#322300,
Advanced Cell Diagnostics) for in situ hybridization (ISH) (Wang
et al., 2012) with predesigned probes for Lhcgr, Ppib (control
reference probe) and DapB (from Bacillus S., nonsense probe) (n ¼
4/group). Hybridization was performed accordingly to manufac-
turer's protocol. Slides were scanned by Pannoramic Midi FL slide
scanner (3DHISTECH Ltd.).
2.8. Statistical analysis
Numerical data were shown as mean ± SEM. Graphs and sta-
tistical analysis using t-test (for 2 experimental groups) or one-way
ANOVA (for groups bigger than 2) followed by the Dunnett's
comparison test were performed using Graph Pad Prism 6 (Graph
Pad Software, San Diego California, USA). We considered p
values < 0.05 statistically signiﬁcant.
3. Results
3.1. Gene expression proﬁling of adrenal tumors of the inha/Tag
mice
cDNA microarray analysis from GDX inha/Tag males and their
Fig. 1. Heatmap of the 50 most differentially expressed genes in GDX inha/Tag vs. GDX WT male mice. In the microarray we found 1810 up-regulated and 1606 down-regulated
genes in tumorous (GDX inha/Tag) vs. healthy (GDX WT) male mice adrenal glands. Green represents up-regulated and red stands for down-regulated probes in GDX inha/Tag vs.
GDX WT (n ¼ 4/group).
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control GDX WT (C57Bl/6N) male littermates revealed 1810 up-
regulated and 1606 down-regulated genes. A heatmap of unsu-
pervised hierarchical clustering of 50 genes is presented in Fig. 1.
Full results of the cDNA microarray analysis are available through
ArrayExpress (accession number E-MTAB-5310). Gene Ontology
(GO) enrichment analyses (Eden et al., 2009) was performed
separately for signiﬁcantly up- (Fig. 2A) and down- (Fig. 2A) regu-
lated genes to classify them into biological processes. Among up-
regulated biological processes were cellular response to stimulus,
G-protein coupled receptor (GPCR) signaling, cellular component
organization or biogenesis, gene expression, cell-cell signaling,
regulation of hormone levels, steroid biosynthetic and metabolic
process, and mitotic cell cycle processes. The most prominent
down-regulated biological processes were animal organ develop-
ment, proteolysis, negative regulation of cell death, ion homeo-
stasis, extracellular matrix organization and cellular response to
gonadotropin stimulus.
3.2. Validation and localization of potential biomarkers
The validation of selected aberrantly expressed genes by qPCR
conﬁrmed signiﬁcant up-regulation of estrogen receptor alpha
(Esr1) and long isoform of prolactin receptor (Prlr-rs1) (Fig. 3A),
whereas Esr2 was not signiﬁcantly changed vs. WT control
(Fig. S1A). Within down-regulated novel genes, there were extra-
cellular matrix regulating compounds such as sarcoglycan delta
(Sgcd) and matrix metallopeptidase 24 (membrane-inserted)
(Mmp24). Other down-regulated genes were cell growth related
genes including insulin-like growth factor 2 (Igf2), E3 ubiquitin-
protein ligase NEDD4 (Nedd4), growth factor receptor-bound pro-
tein 10 (Grb10), RAS-like, estrogen-regulated, growth inhibitor
(Rerg); gonadotropin-releasing hormone receptor (Gnrhr). More-
over, we identiﬁed down-regulation of G-protein coupled receptor
signaling downstream mediators, guanine nucleotide binding
protein, alpha stimulating complex locus (Gnas) and nuclear factor
of activated T cells, cytoplasmic, calcineurin dependent 2 (Nfatc2)
(Fig. 3A). The gene expression proﬁle in males showed identical
pattern with that in females (Fig. S1B). Therefore further validation
studies were conducted only in males. ESR1 protein expressionwas
found in cells of zona glomerulosa of the normal adrenal, whereas
almost all tumor cells expressed ESR1 abundantly (Fig. 3B and C).
Protein expression of GRB10 (Fig. 3DeE), RERG (Fig. 4AeB), GNAS
(Fig. 4CeD), NFATC2 (Fig. 4EeF) were abundant in zona glomer-
ulosa of the normal adrenal, whereas faint or absent in the tumor
foci of inha/Tag adrenals. Moreover, gonadectomy had no impact on
cellular localization of the analyzed biomarkers in WT adrenals
(Fig. S1C-G).
3.3. Lhcgr, GATA4 and GATA6 expression and localization in GDX
normal and neoplastic adrenals
Expression of Lhcgr (Fig. 5A) and Gata4 (Fig. 5B) was up-
regulated, whereas Gata6 (Fig. 5C) was down-regulated in the
tumorigenic adrenals vs. GDX WT. Using RNAscope in situ hybridi-
zation (Wang et al., 2012), we revisited the localization of Lhcgr
expression. GATA4 and GATA6 immunohistochemical localization
was used as validated markers of neoplastic/normal adrenocortical
cells (Chrusciel et al., 2013; Rahman et al., 2001). Lhcgr transcripts
were found in foci scattered in GDX WT adrenal cortex (Fig. 5D), in
most of A cells in GDX WT (Fig. 5E) and abundantly in the adre-
nocortical tumors of inha/Tag mice (Fig. 5F). Moreover, in intactWT
mice Lhcgr localization was similar to GDX WT (Fig. S1H-I). GATA4
was not expressed in the GDXWT adrenal glands (Fig. 5G), but was
abundant in most of the A (Fig. 5H) and adrenocortical tumor cells
(Fig. 5I). GATA6 staining was abundant in the GDX WT adrenal
gland (Fig. 5J), absent in A cells (Fig. 5K) and displayed only a weak
signals in the tumor foci (Fig. 5L).
Fig. 2. Gene Ontology (GO) classiﬁcation (biological processes) of dysregulated genes in adrenocortical tumors vs. GDX WT male mice adrenals. Signiﬁcantly dysregulated
genes were classiﬁed based on the biological processes they are involved in. The analysis shows the number of genes up- (Fig. 2A) or down-regulated (Fig. 2B) in the adrenocortical
tumors of GDX inha/Tag vs. GDX WT.
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3.4. Inverted adrenal-to-gonadal steroidogenic enzyme expression
proﬁle in inha/Tag
From the dysregulated pathways revealed by microarray, we
further analyzed the steroid metabolic enzymes in the inha/Tag
adrenal tumors. GDX inha/Tag mice showed signiﬁcantly increased
plasma levels of LH (Fig. 6A), progesterone (Fig. 6B) compared with
WT and barely detectable levels of testosterone (Fig. 6C). Gene
expression analysis showed signiﬁcant down-regulation of adrenal
(Cyp21a1, Cyp11b1, Cyp11b2) (Fig. 6E) but up-regulation of sex
(Srd5a1, Cyp19a1) (Fig. 6E) steroidogenic enzymes. We found ad-
renal Cyp17a1 was signiﬁcantly increased after gonadectomy (vs.
intact) in WT C57Bl/6 male mice (Supplemental Fig. S2).
4. Discussion
Chronically elevated LH levels after gonadectomy have been
proposed to strain-dependently trigger and modulate Lhcgr
expression in WT (Bernichtein et al., 2008; Bielinska et al., 2003)
and transgenic mice (Kananen et al., 1996; Matzuk et al., 1994).
There is also some evidence for high LH levels affecting human
adrenal function (Alevizaki et al., 2006; Carlson, 2007). We did not
ﬁnd any difference in plasma LH levels between GDX inha/Tag and
WT mice. This implies the involvement of some other factors than
LH action in the tumor formation. In search for such biomarkers, we
ran a cDNA microarray analysis on the GDX inha/Tag vs. GDX WT
adrenals. A validation study conﬁrmed two novel up-regulated
Fig. 3. Validation of the targets suggested by microarray study (part one). (A) Gene expression of signiﬁcantly altered novel potential biomarker genes in GDX inha/Tag males
normalized by GDX WT (baseline) (n ¼ 8/group). Protein localization and optical density comparison of ESR1 (BeC), GRB10 (DeE) in normal adrenal gland (GDX WT) and tumor
tissue (GDX inha/Tag) (n ¼ 4/group). Bar ¼ 50 mm; ZG-zona glomerulosa, ZF- zona fasciculata, X-x-zone.
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(Esr1, Prlr-rs1) and nine down-regulated (Sgcd, Mmp24, Igf2, Nedd4,
Grb10, Rerg, Gnrhr, Gnas, Nfatc2) genes in both males and females.
We did not observe any difference in protein localization between
intact and GDX WT, suggesting that GDX per se did not affect the
gene expression proﬁle.
IHC revealed that ESR1 was expressed in normal zona glomer-
ulosa and in a patchy manner in the tumor cells. This, as well as the
up-regulated Esr1 mRNA expression, pointed to ESR1 as a novel
biomarker of inha/Tag mouse adrenal tumors. Interestingly, Esr1
has been shown to be expressed in B cells of gonadectomized NU/J
mice (Bielinska et al., 2005) and in a subpopulation of tumor cells in
domestic ferrets (Bielinska et al., 2006; Newman et al., 2004).
Therefore, our data supports previous suggestions that
gonadectomy-induced adrenocortical tumors may respond to
estrogen stimuli. On the other hand, normal human adrenals ex-
press both estrogen receptor alpha (ESR1) and beta (ESR2) (Barzon
et al., 2008). In cases of functional ACC, ESR1 was found to be up-
regulated that resulted in an increased ESR1/ESR2 ratio (Barzon
et al., 2008). In our study, gene expression analysis showed Esr1
up-regulation but no signiﬁcant changes in Esr2. Altered ESR1/ESR2
ratio has also been described in estrogen-responsive cancers like
prostate, colon, ovary and breast cancer (Bardin et al., 2004).
Moreover, in the ACC derived cell line H295R, 17b-estradiol exerted
proliferative effect, while antiestrogens were anti-proliferative
(Montanaro et al., 2005). These observations suggest that estro-
gens may contribute to the progression of inha/Tag adrenal tumors.
Whether ESR1 is involved in the induction and progression of the
tumors needs further investigation. It would be interesting to see
Fig. 4. Validation of the targets suggested by microarray study (part two). Protein localization and optical density measurement for RERG (AeB), GNAS (CeD), NFATC2 (EeF) in
normal adrenal gland (GDX WT) vs. tumor foci (GDX inha/Tag) of male mice (n ¼ 4/group). Bar ¼ 50 mm; ZG-zona glomerulosa, ZF- zona fasciculata, X-x-zone.
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the functional consequences of ESR1 knock out on tumor formation
and progression, either in vivo by crossbreeding ESR1/ (ESR1
knock-out mice) and inha/Tagmice, or in vitro by silencing the ESR1
in adrenocortical tumor cells.
PRLR-RS1 protein analysis was not doable due to the lack of
antibodies for speciﬁc prolactin receptor isoforms. IHC staining
results obtained with two different commercially available anti-
bodies for PRLR gave unspeciﬁc staining in mouse tissues. Human
Fig. 5. Expression and localization of neoplastic cell biomarkers. Total RNA gene expression of Lhcgr (A), Gata4 (B), Gata6 (C) in the adrenals of GDX WT and GDX inha/Tag male
mice (mean ± SEM; ***. P  0.001; n ¼ 8/group). Localization of Lhcgr (D, E, F), GATA4 (G, H, I) and GATA6 (J, K, L) in the GDXWT and A cells of GDXWT, and tumor tissue of inha/Tag
mice respectively (n ¼ 4/group). Bar ¼ 50 mm.
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adrenals express functional prolactin receptors (Glasow et al.,
1996). Adrenal stimulation with PRL exerts steroidogenic (Glasow
et al., 1996) but not mitogenic (Glasow et al., 1998) effects. On the
other hand, in bLHb-CTPmice PRL/PRLR signalingwas implicated as
a regulator of LHCGR expression, which in turn lead to adrenocor-
tical tumorigenesis (Kero et al., 2000). Therefore, it would be
interesting to characterize to what extent PRL/PRLR signaling is
involved in the tumor ontogeny and/or steroidogenesis in inha/Tag
mice.
The adrenal gland is one of the major sites of steroid production.
Stem/progenitor cells located in the capsular, subcapsular and
juxtamedullary regions divide and differentiate into cells of zona
glomerulosa or zona fasciculata and x-zone (Pihlajoki et al., 2015).
Moreover, zona glomerulosa and zona fasciculata cells are able to
trans-differentiate into one another to replenish adrenal zones cell
population rapidly (Pihlajoki et al., 2015). In this study, we localized
protein expression of down-regulated target genes like GRB10,
RERG, GNAS, and NFATC2. GNAS and NFATC2 are involved in GPCRs
signaling (Hill et al., 2001) which seems to be more prominent in
the normal adrenal vs. tumor tissue. GRB10 and RERG have not yet
been characterized in the context of the adrenal cortex. Both gene
products seem to inhibit cell proliferation either by inhibition of
insulin and IGF1 action (Liu and Roth, 1995) or GTP hydrolysis
(Finlin et al., 2001), respectively. Their abundant expression in
subcapsular and zona glomerulosa regions suggests their involve-
ment in themaintenance of adrenocortical zonation and perhaps in
the prevention of overgrowth of that region. Although, putative
tumor suppressor role of these downregulated genes could not be
ruled out.
The dysregulated GPCR signaling pathways indicated by GO
analysis prompted us to revisit the Lhcgr expression. LHCGR has
been previously described as a possible trigger for adrenocortical
tumorigenesis in inha/Tag model (Kananen et al., 1996; Mikola
et al., 2003). There is a lack of commercially available good-
quality antibodies against LHCGR. Thus, in this study, we deter-
mined Lhcgr localization by RNAscope in situ hybridization (Wang
et al., 2012). Lhcgr transcripts could be detected in normal adre-
nocortical cells and in A cells of 6-mo intact and GDXWT C57BL/6N
animals. Moreover, we conﬁrmed the robust Lhcgr expression in the
foci of inha/Tag adrenocortical tumor cells (Rahman et al., 2001).
The expression of Lhcgr in A cells has been reported only in GDX
DBA/2J adrenals when accompanied by B cells in gonadotropin-
induced adrenocortical tumors (Bielinska et al., 2003), but not in
the non-susceptible C57bl/6N mouse strain. The role and expres-
sion of Lhcgr in normal mouse adrenal gland remains questionable
since it does not produce androgens (Pihlajoki et al., 2015), albeit a
detectable mRNA level of Lhcgr expression has been shown by PCR-
based methods (Chrusciel et al., 2013; Looyenga and Hammer,
2006). Interestingly, the pattern of Lhcgr localization in normal
cortex is identical in intact and GDXWT animals (Fig. S1), although
total RNA analysis in many studies showed up-regulated levels of
Lhcgr in aging mice after gonadectomy (Chrusciel et al., 2013; Kero
et al., 2000; Looyenga and Hammer, 2006). Recent lineage tracing
studies showed an increase of A cells population after gonadectomy
(Bandiera et al., 2013). This may suggest that the up-regulated Lhcgr
expression after gonadectomy (chronically elevated LH levels)
could be associated with the increase in A cell population, whereas
Lhcgr transcripts in normal intact adrenal remain unchanged. One
Fig. 6. Hormonal and steroidogenic enzymes proﬁle of adrenocortical tumor bearing inha/Tag male mice. Plasma levels of LH (A), progesterone (B), and testosterone (C) in
intact WT, and GDX WT and inha/Tag males (n ¼ 6e9/group). Gene expression of signiﬁcantly altered adrenal (D) and gonadal (E) steroidogenic enzymes in GDX inha/Tag vs. GDX
WT. (n ¼ 8/group; mean ± SEM; *. P  0.05. **. P  0.01. ***. P  0.001.)
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of the current theories of steroidogenic lipid-laden B cells origin
suggests that A cells differentiate into B cells upon exposure to high
LH concentration (Bielinska et al., 2003). This suggests that the
Lhcgr expression in A cells could be crucial trigger for B cell for-
mation. Therefore, it is possible that despite their gonadotropin
independent induction, A cells could respond to LH action later on.
The reciprocal expression of GATA4 and GATA6 in the adreno-
cortical tumors of inha/Tag and Inha/- mice has been reported
earlier (Looyenga and Hammer, 2006; Vuorenoja et al., 2007). In
our study GATA4 expression appeared to be restricted to neoplastic
A cells (GDXWT and inha/Tag) and tumor tissue (inha/Tag), and no
staining was seen in normal adrenal tissue. Since GATA4 was also
expressed in B cells of GDX DBA/2J (Chrusciel et al., 2013; Krachulec
et al., 2012) and in adrenal carcinoma cells of Inha/- mice
(Looyenga and Hammer, 2006), we could conﬁrm that GATA4 could
be used as a neoplastic cell marker in mouse adrenal tumor models.
GATA6 expressionwas found mainly in normal adrenocortical cells,
and in some tumor cells, but it was never found in A cells. Recently
it was shown that GATA6 is crucial for normal adrenal development
and when absent, adrenocortical progenitors tend to differentiate
into neoplastic A cells (Pihlajoki et al., 2013). In turn, GATA4 triggers
neoplastic B-cell formation (Chrusciel et al., 2013; Krachulec et al.,
2012) and is most likely responsible for their gonadal-like gene
expression proﬁle (Chrusciel et al., 2013; Krachulec et al., 2012;
Looyenga and Hammer, 2006). However, in transgenic mice
expressing GATA4 under the 21-hydroxylase promoter (21-OH-
GATA-4), GATA4 expression was not sufﬁcient to cause B-cell for-
mation without a gonadectomy-induced gonadotropin boost
(Chrusciel et al., 2013). Most likely in all gonadectomy-induced
adrenocortical tumorigenesis models, gonadotropins act up-
stream of the tumorigenesis, but the mechanism of their involve-
ment in this process remains unknown. Until now, only in the
Inha/- mouse model this mechanism has been proposed and FSH
was identiﬁed to work as an upstream inductor to switch on the
GATA6 to GATA4 transition (Looyenga and Hammer, 2006). In
Inha/- mice, similarly to our studies, attenuation of GATA6 and
induction of GATA4 expression in neoplastic tissue was observed
(Looyenga and Hammer, 2006). It would be interesting to see if the
silencing of the LH/LHCGR signaling in inha/Tag or in DBA/2J or
Inha/- mice would block the adrenocortical tumorigenesis.
Enrichment analysis of the microarray data indicated dysregu-
lation of steroid biosynthesis and metabolism. Validation data
showed that tumor cells in inha/Tag mice have decreased expres-
sion of genes of adrenal steroidogenic pathway and rather express
sex steroidogenic enzymes. Interestingly, in contrast to signiﬁcantly
increased Cyp19a1 and Srd5a1, expression of Cyp17a1 was not
altered in our experimental model (GDX inha/Tag vs. GDX WT). A
recent study showed a signiﬁcant increase of adrenal CYP17A1
expression after gonadectomy (vs. intact) in a C57Bl/6 background
(Bandiera et al., 2013). We also found signiﬁcantly increased ad-
renal Cyp17a1 after gonadectomy in WT C57Bl/6 mice. Our results
suggest that in C57Bl/6 background, Cyp17a1 expression could be
upregulated in WT C57Bl/6 adrenal as a consequence of gonadec-
tomy, but not due to adrenocortical tumor onset as it was observed
in gonadectomized DBA/2J mice (Bielinska et al., 2003; Krachulec
et al., 2012). Production of estrogen by tumorous adrenals of GDX
DBA/2J mice (Bielinska et al. 2003, 2005) and low levels of testos-
terone found in GDX inha/Tag males indicates that the sex steroid
production is a common feature in models susceptible to gonado-
tropin dependent tumorigenesis (Bielinska et al. 2003, 2005;
Krachulec et al., 2012).
The counterpart to gonadectomy-induced adrenocortical tu-
mors are the adrenal rest tumors in gonads, where high adreno-
corticotropin (ACTH) levels induce adrenal cell-like tumors in
gonads (Claahsen-Van der Grinten et al., 2009). The current
theories claim that they originate from either adrenal progenitors
‘trapped’ in gonads or somatic testicular cells expressing receptors
for ACTH (MC2R) (Claahsen-Van der Grinten et al., 2009). Therefore,
elevated ACTH levels (i.e. as a result of congenital adrenal hyper-
plasia) stimulate expression of adrenal markers and drive forma-
tion of benign testicular adrenal rest tumors (Claahsen-Van der
Grinten et al., 2009).
In conclusion, we found ESR1 as a potential biomarker of
adrenocortical tumorigenesis in inha/Tag mice. In functional ACC,
ESR1 has been already found to be up-regulated, thus the clinical
relevance is already there, although this has not been studied
further (Barzon et al., 2008). We also identiﬁed novel genes, Grb10,
Rerg, Gnas, and Nfatc2, which are most likely involved in normal
adrenal remodeling and/or as tumor suppressor genes. We also
found low levels of Lhcgr transcripts in normal adrenocortical cells
and in neoplastic A cells of intact and GDX C57Bl/6N WT mice.
Adrenocortical tumors bearing inha/Tag mice presented with an
inverted adrenal-to-gonadal proﬁle of steroidogenic enzymes
expression. It would be of great importance to check the genes with
suppressed expression in human ACT, as this mouse model
tumorigenesis resembles human tumors. Thus these genes may
have human relevance and could be further considered as potential
diagnostic and therapeutic tools in human tumors with similar
molecular pathogenesis.
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